(Q40156868)

18 September 2017

title

Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells (English)

1 reference

18 September 2017

main subject

hepatocellular carcinoma

1 reference

Mengde Cao

1

1 reference

18 September 2017

Roniel Cabrera

2

1 reference

18 September 2017

Yiling Xu

3

1 reference

18 September 2017

Roberto Firpi

4

1 reference

18 September 2017

Haizhen Zhu

5

1 reference

18 September 2017

Chen Liu

6

1 reference

18 September 2017

David R Nelson

7

1 reference

18 September 2017

publication date

19 March 2007

1 reference

18 September 2017

published in

Laboratory Investigation

1 reference

18 September 2017

volume

87

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

582-590

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700540

18 September 2017

exact match

0 references

cites work

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

CD25+ CD4+ regulatory T-cells in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Certified professionals: CD4(+)CD25(+) suppressor T cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Immunophenotypes and cytotoxic functions of lymphocytes in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Foxp3 and natural regulatory T cells: key to a cell lineage?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Human CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Persistence of naive CD45RA+ regulatory T cells in adult life.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700540

7 January 2021

10.1038/LABINVEST.3700540

Identifiers

DOI

1 reference

18 September 2017

1 reference